Medline Cash Flow Statement
NASDAQ: MDLNHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medline free cash flow
In fiscal 2025, Medline generated $1.74 billion of operating cash flow and spent $447.0 million on capital expenditures. That left free cash flow of $1.30 billion, a free-cash-flow margin of 4.6% of revenue. Medline returned $33.0 million to shareholders through share repurchases, equal to 3% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Medline cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20252025-12-16 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|---|
| Net Income | 1.16B | 1.15B | 1.16B | 234.00M |
| Net Income growth (YoY) | +0.52% | -0.86% | +397.01% | — |
| Depreciation & Amortization | 1.01B | — | 977.00M | 951.00M |
| Stock-Based Compensation | 76.00M | — | 61.00M | 78.00M |
| Change in Working Capital | -691.00M | — | -737.00M | 311.00M |
| Operating Cash Flow | 1.74B | — | 1.77B | 1.69B |
| Capital Expenditures | -447.00M | — | -354.00M | -275.00M |
| Investing Cash Flow | -474.00M | — | -1.49B | -312.00M |
| Share Repurchases | -33.00M | — | -20.00M | 0 |
| Financing Cash Flow | 399.00M | — | -1.61B | -191.00M |
| Net Change in Cash | 1.69B | — | -1.33B | 1.19B |
| Free Cash Flow | 1.30B | — | 1.42B | 1.41B |
This table shows 4 annual periods of Medline's cash flow statement, from FY 2025 back to FY 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MDLN's reporting calendar. What is a cash flow statement?